國家衛生研究院 NHRI:Item 3990099045/12038
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 911940      線上人數 : 1044
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12038


    題名: Hemodynamics-based strategy of using retinoic acid receptor and retinoid X receptor agonists to induce microRNA-10a and inhibit atherosclerotic lesion
    作者: Lee, DY;Chiu, JJ
    貢獻者: Institute of Cellular and Systems Medicine
    摘要: The protocols in this chapter describe methods for identifying the functional roles of retinoic acid receptor (RAR) and retinoid X receptor (RXR) signaling in atherosclerosis and developing RARalpha/RXRalpha-specific agonists as hemodynamics-based therapeutic components for atherosclerosis treatment. In vitro cell culture flow system is used to elucidate the effects of different flow patterns and shear stresses, i.e., atherogenic oscillatory shear stress (OS) vs. atheroprotective pulsatile shear stress (PS), on RAR/RXR signaling and inflammatory responses in vascular endothelial cells (ECs). Western blotting, nuclear and cytoplasmic protein extraction, immunoprecipitation, and in situ proximity ligation assay are used to examine the expression, location, and association of RARs (i.e., RARalpha, RARbeta, and RARgamma) and RXRs (i.e., RXRalpha, RXRbeta, and RXRgamma) in ECs in response to OS vs. PS. Chromatin immunoprecipitation is used to examine the binding activity of RARalpha/RA-responsive elements (RARE). RT-microRNA (miR) quantitative real-time PCR and RT-PCR are used to detect the expressions of miR-10a and pro-inflammatory molecules, respectively. Specific siRNAs of RARalpha and RXRalpha, precursor miR-10a (PreR-10a), and antagomiR-10a (AMR-10a) are used to elucidate the regulatory roles of RARalpha, RXRalpha, and miR-10a in pro-inflammatory signaling in ECs. RARalpha/RXRalpha-specific agonists are used to induce miR-10a expression and inhibit OS-induced pro-inflammatory signaling in ECs in vitro. Apolipoprotein E-deficient (ApoE(-/-)) mice are used as an atherosclerotic animal model. Administration of ApoE(-/-) mice with RARalpha/RXRalpha-specific agonists results in inhibitions in atherosclerotic lesion formation. Co-administration of ApoE(-/-) mice with RARalpha/RXRalpha agonists and AMR-10a is performed to identify the role of miR-10a in RARalpha/RXRalpha agonists-mediated inhibition in atherosclerotic lesions. Oil Red O staining and H&E staining are used to examine the levels of atherosclerotic lesions in the vessel wall. In situ miR hybridization and immunohistochemical staining are used to detect the expression of miR-10a and pro-inflammatory molecules and the infiltration of inflammatory cells in the vessel wall. RARalpha/RXRalpha-specific agonists are used to mimic the atheroprotective effects of PS to induce endothelial miR-10a and hence repress OS-induced pro-inflammatory signaling and atherosclerotic lesion formation in vivo. The results indicate that RAR/RXR-specific agonists have great potential to be developed as hemodynamics-based therapeutic components for atherosclerosis treatment.
    日期: 2019-07-30
    關聯: Methods in Molecular Biology. 2019 Jul 30;2019:143-169.
    Link to: http://dx.doi.org/10.1007/978-1-4939-9585-1_11
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85070539113
    顯示於類別:[裘正健] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB31359395.pdf675KbAdobe PDF256檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋